Deallus latest news

The latest news from Deallus pharmaceutical and life science industry experts

BIO 2022: Biotechnology Innovation Organization (BIO) Convention


We’re excited to be attending The BIO International Convention. Jack Florio, Partner in Strategy Consulting at Deallus will be joining more than 3,000 delegates and exploring the latest innovation within the biotech space, as well as making the most of opportunities to meet and network with global thought leaders and industry peers.

ASCO 2022 Summary of findings in oncology and China market


China is never a new word in ASCO. China-originated innovation made its ASCO debut in 2011, and since then we have been seeing more Chinese pharma bringing exciting clinical progress in the oncology space. This year, there will be 19 oral presentations and more than 70 posters from Chinese pharma, with the keyword 'China’ hit a record high of nearly 350 times in the ASCO Agenda.

Deallus welcomes Kunal Kaushal Principal, New York


Deallus welcomes Kunal Kaushal as a Principal in the New York office. Kunal brings more than 14 years of strategy consulting and advisory experience to the role, his expertise spanning many different project types, geographies, and therapeutic areas. His TA focus includes Oncology, Cardiovascular, Gastrointestinal, Anti-Obesity and Rheumatology.

Go to Top